{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:28:08Z","timestamp":1783636088199,"version":"3.55.0"},"reference-count":49,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["U1111-1209-6358"],"award-info":[{"award-number":["U1111-1209-6358"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Faster-acting insulin aspart (Fiasp) is approved for use in pregnancy and lactation, but no clinical study has evaluated its effects during this life stage in women with pre-existing diabetes. The aim of the CopenFast trial is to evaluate the effect of Fiasp compared with insulin aspart (NovoRapid) on maternal glycaemic control during pregnancy, delivery and lactation and on fetal growth and infant health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>An open-label randomised controlled trial of pregnant women with type 1 or type 2 diabetes including women on multiple daily injection (MDI) therapy or insulin pump therapy. During a 2-year inclusion period, approximately 220 women will be randomised 1:1 to Fiasp or NovoRapid in early pregnancy and followed until 3\u2009months after delivery. At 9, 21 and 33 gestational weeks and during planned induction of labour or caesarean section, women are offered blinded continuous glucose monitoring (CGM) for 7\u2009days. Randomisation will stratify for type of diabetes and insulin treatment modality (MDI or insulin pump therapy, respectively). Health status of the infants will be followed until 3\u2009months of age. The primary outcome is birth weight SD score adjusted for gestational age and gender. Secondary outcomes include maternal glycaemic control including glycated haemoglobin, preprandial and postprandial self-monitored plasma glucose levels, episodes of mild and severe hypoglycaemia, maternal gestational weight gain and weight retention, CGM time spent in, above and below target ranges as well as pregnancy outcomes including pre-eclampsia, preterm delivery, perinatal mortality and neonatal morbidity. Data analysis will be performed according to the intention-to-treat principle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial has been approved by the Regional Ethics Committee (H-19029966) on 7 August 2019. Results will be sought disseminated in peer-reviewed journals and at scientific meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03770767\">NCT03770767<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-045650","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T12:46:02Z","timestamp":1617972362000},"page":"e045650","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03770767","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-5755","authenticated-orcid":false,"given":"Sidse Kj\u00e6rhus","family":"N\u00f8rgaard","sequence":"first","affiliation":[{"name":"Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Reinhardt","family":"Mathiesen","sequence":"additional","affiliation":[{"name":"Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"N\u00f8rgaard","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Gentofte, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Dalsgaard","family":"Clausen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"},{"name":"Department of Gynaecology and Obstetrics, Nordsjaellands Hospital, Hillerod, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damm","sequence":"additional","affiliation":[{"name":"Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"},{"name":"Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Ringholm","sequence":"additional","affiliation":[{"name":"Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"2025121509265332000_11.4.e045650.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0896"},{"key":"2025121509265332000_11.4.e045650.2","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00125-017-4314-3","article-title":"Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study","volume":"60","author":"Murphy","year":"2017","journal-title":"Diabetologia"},{"key":"2025121509265332000_11.4.e045650.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2012.01412.x"},{"key":"2025121509265332000_11.4.e045650.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2721-z"},{"key":"2025121509265332000_11.4.e045650.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1755"},{"key":"2025121509265332000_11.4.e045650.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2406"},{"key":"2025121509265332000_11.4.e045650.7","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.12.2819"},{"key":"2025121509265332000_11.4.e045650.8","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.2.323"},{"key":"2025121509265332000_11.4.e045650.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0305"},{"key":"2025121509265332000_11.4.e045650.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0197-3"},{"key":"2025121509265332000_11.4.e045650.11","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-020-01315-x","article-title":"Diabetes management during breastfeeding in women with type 1 diabetes","volume":"20","author":"Ringholm","year":"2020","journal-title":"Curr Diab Rep"},{"key":"2025121509265332000_11.4.e045650.12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14767058.2014.906577","article-title":"Dietary advices on carbohydrate intake for pregnant women with type 1 diabetes","volume":"28","author":"Roskj\u00e6r","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025121509265332000_11.4.e045650.13","doi-asserted-by":"publisher","DOI":"10.4158\/EP.14.2.239"},{"key":"2025121509265332000_11.4.e045650.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1887"},{"key":"2025121509265332000_11.4.e045650.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.08.005"},{"key":"2025121509265332000_11.4.e045650.16","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0473-5"},{"key":"2025121509265332000_11.4.e045650.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1771"},{"key":"2025121509265332000_11.4.e045650.18","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13545"},{"key":"2025121509265332000_11.4.e045650.19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dom.13610","article-title":"A randomized, multicentre trial evaluating the efficacy and safety of fast\u2010acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)","volume":"21","author":"Klonoff","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2025121509265332000_11.4.e045650.20","unstructured":"European Medicines Agency . Fiasp summary of product characteristics [online], 2017. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/fiasp [Accessed 31 Jul 2020]."},{"key":"2025121509265332000_11.4.e045650.21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/dia.2012.0260","article-title":"Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study","volume":"15","author":"Fresa","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"2025121509265332000_11.4.e045650.22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/dme.13106","article-title":"Insulin pump use compared with intravenous insulin during labour and delivery: the inspired observational cohort study","volume":"33","author":"Drever","year":"2016","journal-title":"Diabet Med"},{"key":"2025121509265332000_11.4.e045650.23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/AOG.0000000000003940","article-title":"Evaluation of an intrapartum insulin regimen for women with diabetes","volume":"136","author":"Dude","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2025121509265332000_11.4.e045650.24","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1348"},{"key":"2025121509265332000_11.4.e045650.25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15277\/bjdvd.2015.026","article-title":"Post-partum hypoglycaemia in lactating women with type 1 diabetes: a pilot study using continuous glucose monitoring","volume":"15","author":"Inkster","year":"2015","journal-title":"Br J Diabetes"},{"key":"2025121509265332000_11.4.e045650.26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4158\/EP.15.3.187","article-title":"Breastfeeding and the basal insulin requirement in type 1 diabetic women","volume":"15","author":"Riviello","year":"2009","journal-title":"Endocr Pract"},{"key":"2025121509265332000_11.4.e045650.27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00125-018-4794-9","article-title":"Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy","volume":"62","author":"Ringholm","year":"2019","journal-title":"Diabetologia"},{"key":"2025121509265332000_11.4.e045650.28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/dme.12993","article-title":"Glycaemic behaviour during breastfeeding in women with type 1 diabetes","volume":"33","author":"Achong","year":"2016","journal-title":"Diabet Med"},{"key":"2025121509265332000_11.4.e045650.29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/dia.2011.0266","article-title":"Continuous glucose monitoring during breastfeeding in women with recent gestational diabetes mellitus","volume":"14","author":"Colatrella","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"2025121509265332000_11.4.e045650.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1243"},{"key":"2025121509265332000_11.4.e045650.31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121509265332000_11.4.e045650.32","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d9d421"},{"key":"2025121509265332000_11.4.e045650.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2010.01779.x"},{"key":"2025121509265332000_11.4.e045650.34","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1066"},{"key":"2025121509265332000_11.4.e045650.35","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.377"},{"key":"2025121509265332000_11.4.e045650.36","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2480"},{"key":"2025121509265332000_11.4.e045650.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.02958.x"},{"key":"2025121509265332000_11.4.e045650.38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/dia.2015.0246","article-title":"A study of the carbohydrate-to-insulin ratio in pregnant women with type 1 diabetes on pump treatment","volume":"18","author":"Bongiovanni","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"2025121509265332000_11.4.e045650.39","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14767058.2013.837444","article-title":"Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes","volume":"27","author":"Mathiesen","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025121509265332000_11.4.e045650.40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjd.2021.01.006","article-title":"Do-it-yourself artificial pancreas system use in pregnant women with type 1 diabetes in a real-world setting: 2 case reports","author":"Lemieux","year":"2021","journal-title":"Can J Diabetes"},{"key":"2025121509265332000_11.4.e045650.41","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/1932296820906219","article-title":"Two subsequent pregnancies in a woman with type 1 diabetes: artificial pancreas was a Gamechanger","volume":"14","author":"Sch\u00fctz-Fuhrmann","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2025121509265332000_11.4.e045650.42","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12246"},{"key":"2025121509265332000_11.4.e045650.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1996.tb14164.x"},{"key":"2025121509265332000_11.4.e045650.44","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"2025121509265332000_11.4.e045650.45","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.441"},{"key":"2025121509265332000_11.4.e045650.46","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12429"},{"key":"2025121509265332000_11.4.e045650.47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabres.2018.02.014","article-title":"Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes","volume":"138","author":"N\u00f8rgaard","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2025121509265332000_11.4.e045650.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6802"},{"key":"2025121509265332000_11.4.e045650.49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.diabres.2019.05.012","article-title":"Lower daily carbohydrate consumption than recommended by the Institute of medicine is common among women with type 2 diabetes in early pregnancy in Denmark","volume":"152","author":"\u00c1sbj\u00f6rnsd\u00f3ttir","year":"2019","journal-title":"Diabetes Res Clin Pract"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-045650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:27:00Z","timestamp":1765819620000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-045650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,9]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bmjopen-2020-045650"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-045650","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}